Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03115710 · ClinicalTrials.gov registry record
The K-Map Study, Global Prevalence of KC
A clinical trial of Keratoconus, sponsored by University Hospital, Geneva.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 12
- Study locations
NCT03115710: Recruiting study of Keratoconus, sponsored by University Hospital, Geneva.
NCT03115710 is a study of Keratoconus that is actively recruiting participants, run by University Hospital, Geneva. The registered enrollment target is 20,000 participants, above the 228-participant average among 21 other Keratoconus trials with a reported enrollment target (8672% higher). The trial reports 12 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03115710, a study of Keratoconus, is actively recruiting participants, sponsored by University Hospital, Geneva.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss. The overall goal of this study is to assess the prevalence of keratoconus (KC) in children and adolescents in various regions of the world based on modern tomographic imaging methods, and to verify whether the occurrence rates reported from literature should be corrected. Our hypothesis is that the prevalence of the disease is much higher than that traditionally reported. At each site, corneal tomography examinations (Pentacam) will be performed bilaterally in children and adolescents, who are not ill or with any ophthalmological symptom. The population to be studied will be composed of children and adolescents on medical visits for non-ophthalmologic reasons, aged between 6 and 20 years. Multiple cities, from different continents (North America, South America, Asia and Europe) will participate.
Primary Outcome
Number of keratoconus cases detected
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Rotating Scheimpflug camera (Pentacam HR)
Study Locations (12)
Other
- Eye Hospital of Wenzhou Medical College - Wenzhou
- - Zagreb
- - Alexandria
- - Homburg
- - Isfahan
- - Amman
- - Monterrey
- - Lima
- Ufa Eye Research Intitute - Ufa
- King Saud University - Riyadh
- - Bukhara
California
- USC Roski Eye Institute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2015-12-28 |
| Est. Completion | 2030-02-01 |
What NCT03115710 shows while recruiting
NCT03115710 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 228-participant average among 21 other Keratoconus trials with a reported enrollment target (8672% higher).
The record links to 1 condition, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which Rotating Scheimpflug camera (Pentacam HR) is the first listed.
NCT03115710 lists 12 locations in 2 states (Other, California).
Frequently Asked Questions
What is clinical trial NCT03115710 about?
NCT03115710 is a clinical study titled "The K-Map Study, Global Prevalence of KC". Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss. The overall goal of this study is to assess the prevalence of keratoconus (KC) in childr...
What is the current status of trial NCT03115710?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2015-12-28. Estimated completion is 2030-02-01.
What conditions does trial NCT03115710 study?
This clinical trial studies the following conditions: Keratoconus.
What interventions are being tested in trial NCT03115710?
The interventions under investigation include: Rotating Scheimpflug camera (Pentacam HR) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03115710?
This trial is sponsored by University Hospital, Geneva, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03115710 being conducted?
This trial has 12 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03115710's enrollment target sits among peer trials
20,000 1st of 21 higher than 21 of 21 other Keratoconus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keratoconus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
-
Collagen Cross-linking in Keratoconus
RECRUITING · NA
-
Corneal Elastography and Patient Specific Modeling
RECRUITING
-
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI